Xylem
671 hedge funds and large institutions have $10.4B invested in Xylem in 2020 Q1 according to their latest regulatory filings, with 62 funds opening new positions, 264 increasing their positions, 251 reducing their positions, and 96 closing their positions.
19% more call options, than puts
Call options by funds: $19.4M | Put options by funds: $16.4M
1.01% more ownership
Funds ownership: 88% → 89.01% (+1%)
5% more repeat investments, than reductions
Existing positions increased: 264 | Existing positions reduced: 251
5% less funds holding
Funds holding: 709 → 671 (-38)
16% less capital invested
Capital invested by funds: $12.5B → $10.4B (-$2.05B)
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
35% less first-time investments, than exits
New positions opened: 62 | Existing positions closed: 96
Top Buyers
| 1 |
Aristotle Capital Management
Los Angeles,
California
|
+$654M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
+$215M |
| 3 |
BlackRock
New York
|
+$177M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$34.6M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$30.3M |
Top Sellers
XYL Hedge Fund Activity: Q1 2020 in Review
671 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Xylem (XYL) for Q1 2020, worth a combined $10.4B — down 16% from $12.5B a quarter earlier.
Sellers outnumbered buyers: 96 funds closed out of XYL and 62 opened new positions — a net loss of 34 holders — while 251 trimmed existing stakes and 264 added.
The largest buyer was Aristotle Capital Management, opening a new position worth an estimated $654M. The largest seller was T. Rowe Price Associates, cutting an estimated $333M.
- 671 institutional investors held Xylem (XYL) as of Q1 2020, down from 709 in Q4 2019.
- Funds reported $10.4B of Xylem stock for Q1 2020, down 16% quarter-over-quarter.
- 62 funds opened new Xylem positions in Q1 2020 and 96 closed out, a net change of -34 holders.
- The largest Xylem buyer in Q1 2020 was Aristotle Capital Management, an estimated $654M added.
- The largest Xylem seller in Q1 2020 was T. Rowe Price Associates, an estimated $333M sold.
Based on aggregated 13F filings for Q1 2020.